Emil E. Hassan - 05 May 2022 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Emil E. Hassan
Issuer symbol
NHC
Transactions as of
05 May 2022
Net transactions value
+$547,050
Form type
4
Filing time
06 May 2022, 15:28:32 UTC
Previous filing
21 May 2021
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $547,050 +7,500 +11% $72.94 78,595 05 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -7,500 -100% $0.000000* 0 05 May 2022 Common Stock 7,500 $72.94 Direct
transaction NHC Option to Purchase Common Stock [2022 Grant] Award $0 +7,500 $0.000000 7,500 05 May 2022 Common Stock 7,500 $69.19 Direct F2
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $61.90 Direct
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $77.92 Direct
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $64.64 Direct
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $71.64 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).